According to BioAtla CEO Jai Short, therapeutic antibodies for various types of cancer treatment will be produced (30 % related to lung cancer), and the Hefei center will develop in the world’s largest center for antibody production, with about 100 target antibodies. Bioatla has operations in San Diego and Peking. The project is in cooperation with Peking University.

China Bio news release, Jan. 28, 2015